Hong WK - Search Results

1

Loss of PTEN expression as a prognostic marker for tongue cancer.

Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD, Hong WK, Mao L. Lee JI, et al. Among authors: hong wk. Arch Otolaryngol Head Neck Surg. 2001 Dec;127(12):1441-5. doi: 10.1001/archotol.127.12.1441. Arch Otolaryngol Head Neck Surg. 2001. PMID: 11735811

2

Loss of Fhit expression is a predictor of poor outcome in tongue cancer.

Lee JI, Soria JC, Hassan K, Liu D, Tang X, El-Naggar A, Hong WK, Mao L. Lee JI, et al. Among authors: hong wk. Cancer Res. 2001 Feb 1;61(3):837-41. Cancer Res. 2001. PMID: 11221865

3

Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.

Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Hassan KA, et al. Among authors: hong wk. Clin Cancer Res. 2001 Aug;7(8):2458-62. Clin Cancer Res. 2001. PMID: 11489826

4

Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK, Mao L. Hassan KA, et al. Among authors: hong wk. Cancer Res. 2002 Nov 15;62(22):6414-7. Cancer Res. 2002. PMID: 12438226

5

Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.

Tai SK, Lee JI, Ang KK, El-Naggar AK, Hassan KA, Liu D, Lee JJ, Ren H, Hong WK, Mao L. Tai SK, et al. Among authors: hong wk. Clin Cancer Res. 2004 Aug 15;10(16):5554-7. doi: 10.1158/1078-0432.CCR-04-0208. Clin Cancer Res. 2004. PMID: 15328196 Clinical Trial.

6

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR. Lu C, et al. Among authors: hong wk. J Clin Oncol. 2004 Nov 15;22(22):4575-83. doi: 10.1200/JCO.2004.01.091. J Clin Oncol. 2004. PMID: 15542809

7

Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis.

Massarelli E, Brown E, Tran NK, Liu DD, Izzo JG, Lee JJ, El-Naggar AK, Hong WK, Papadimitrakopoulou VA. Massarelli E, et al. Among authors: hong wk. Cancer. 2005 Mar 1;103(5):952-9. doi: 10.1002/cncr.20879. Cancer. 2005. PMID: 15666322 Free article.

8

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.

Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY. Chang YS, et al. Among authors: hong wk. Clin Cancer Res. 2002 Dec;8(12):3796-802. Clin Cancer Res. 2002. PMID: 12473592

9

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L. Ren H, et al. Among authors: hong wk. J Clin Oncol. 2004 Aug 15;22(16):3230-7. doi: 10.1200/JCO.2004.02.080. J Clin Oncol. 2004. PMID: 15310766

10

A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.

Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW. Wang L, et al. Among authors: hong wk. Int J Oncol. 2004 Oct;25(4):993-9. Int J Oncol. 2004. PMID: 15375549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

760 results

Search Page

Filters